China: Johnson & Johnson monopoly ruling hits several milestones for antitrust law
Johnson & Johnson became the first Fortune 500 company to be ruled a monopoly by a Chinese court, say reports. The decision reflects the nation’s strengthening position against price-fixing, say analysts. The verdict, delivered Thursday, ordered the US-based pharmaceutical giant to pay about $86,500 to an ex-dealer on which J&J imposed a price floor, said the Shanghai High People’s Court. The company forced minimum retail prices on its former China-based dealer Rainbow Medical. Chief judge Ding Wenlian said the medical instrument market in the nation has “faced a lack of competition. The ruling marks the first antitrust ruling in favor of the plaintiff, and the first vertical monopoly lawsuit in China since the establishment of the nation’s Anti-monopoly Law, which went into effect five years ago.
Full Content: China Daily
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Google Requests Judge, Not Jury, to Decide on Antitrust Case
May 19, 2024 by
CPI
Apple Faces Contempt Hearings Over App Store Reforms
May 19, 2024 by
CPI
T-Mobile Faces Class-Action Lawsuit Over Sprint Merger After Appeal Denied
May 16, 2024 by
CPI
Google Faces Backlash Over Introduction of AI-Generated Summaries in Searches
May 16, 2024 by
CPI
CMA Launches Phase 2 Probe into AlphaTheta’s Acquisition of Serato
May 16, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Ecosystems
May 9, 2024 by
CPI
Mapping Antitrust onto Digital Ecosystems
May 9, 2024 by
CPI
Ecosystems and Competition Law: A Law and Political Economy Approach
May 9, 2024 by
CPI
Ecosystem Theories of Harm: What is Beyond the Buzzword?
May 9, 2024 by
CPI
Open Ecosystems: Benefits, Challenges, and Implications for Antitrust
May 9, 2024 by
CPI